Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy OncoSec Medical stock (ONCS)

Buy OncoSec Medical stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

OncoSec Medical is a biotechnology & medical research business based in the US. OncoSec Medical shares (ONCS) are listed on the NASDAQ and all prices are listed in US Dollars. OncoSec Medical employs 40 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy OncoSec Medical stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for Investing by theme

Go to site
Earn up to $300 on new deposits
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy OncoSec Medical stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – ONCS. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy OncoSec Medical stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder Score: 4.4 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Finder Score: 3.1 / 5: ★★★★★
Stocks, ETFs
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Finder Score: 4.3 / 5: ★★★★★
Stocks, Options, ETFs
Up to 8.10%
Get up to 15 free stocks
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Finder Score: 4.2 / 5: ★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

OncoSec Medical stock price (NASDAQ: ONCS)

Use our graph to track the performance of ONCS stocks over time.

OncoSec Medical shares at a glance

Information last updated 2023-10-22.
Latest market close$0.00
52-week range$0.00 - $0.07
50-day moving average $0.42
200-day moving average $2.64
Wall St. target price$110.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-20.31

Is it a good time to buy OncoSec Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

OncoSec Medical price performance over time

Historical closes compared with the close of $0.0002 from 2023-08-25

1 week (2024-07-13) N/A
1 month (2024-06-20) N/A
3 months (2024-04-20) N/A
6 months (2024-01-20) N/A
1 year (2023-07-24) -99.66%
2 years (2022-07-22) -99.97%
3 years (2021-07-23) 2.23
5 years (2019-07-24) 2.2

OncoSec Medical financials

Gross profit TTM $0
Return on assets TTM -92.84%
Return on equity TTM -410.17%
Profit margin 0%
Book value $-1.85
Market Capitalization $1.7 million

TTM: trailing 12 months

OncoSec Medical share dividends

We're not expecting OncoSec Medical to pay a dividend over the next 12 months.

Have OncoSec Medical's shares ever split?

OncoSec Medical's shares were split on a 1:22 basis on 8 November 2022. So if you had owned 22 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your OncoSec Medical shares – just the quantity. However, indirectly, the new 2100% higher share price could have impacted the market appetite for OncoSec Medical shares which in turn could have impacted OncoSec Medical's share price.

OncoSec Medical share price volatility

Over the last 12 months, OncoSec Medical's shares have ranged in value from as little as $0.0002 up to $0.0699. A popular way to gauge a stock's volatility is its "beta".

ONCS.US volatility(beta: 2)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OncoSec Medical's is 1.9989. This would suggest that OncoSec Medical's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

OncoSec Medical overview

OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company's product pipeline includes KEYNOTE-695, which is in Phase 2 trial for the treatment of advanced melanoma; TAVO + SARS-CoV-2 spike glycoprotein, which is in Phase 1 clinical trial for the treatment of COVID-19; and TAVO + epacadostat + pembrolizumab, which is in Phase 1 clinical trial for the treatment of squamous cell carcinoma head and neck cancer. Its pipeline also comprises TAVO +nivolumab, which is in Phase 2 clinical trial for the treatment of breast cancer; TAVO + CXCL9 for the treatment of solid tumors; and OMS-100 and OMS-102, which are in Phase 2 clinical trial for the treatment of metastatic melanoma. OncoSec Medical Incorporated has clinical trial collaborations with Merck & Co. , Inc. and its subsidiary in connection with the KEYNOTE-695 and KEYNOTE-890; and a research collaboration with Duke University's Center for Applied Therapeutics to evaluate TAVO in combination or sequenced with a HER2-plasmid vaccine. The company was formerly known as NetVentory Solutions Inc.

Frequently asked questions

What percentage of OncoSec Medical is owned by insiders or institutions?
Currently 28.014% of OncoSec Medical shares are held by insiders and 5.831% by institutions.
How many people work for OncoSec Medical?
Latest data suggests 40 work at OncoSec Medical.
When does the fiscal year end for OncoSec Medical?
OncoSec Medical's fiscal year ends in July.
Where is OncoSec Medical based?
OncoSec Medical's address is: 24 North Main Street, Pennington, NJ, United States, 08534
What is OncoSec Medical's ISIN number?
OncoSec Medical's international securities identification number is: US68234L3069
What is OncoSec Medical's CUSIP number?
OncoSec Medical's Committee on Uniform Securities Identification Procedures number is: 68234L306

More guides on Finder

Ask a question provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site